Vincent Medical Holdings Management
Management criteria checks 3/4
Vincent Medical Holdings' CEO is Raymond Choi, appointed in Jan 2023, has a tenure of 1.33 years. total yearly compensation is HK$1.52M, comprised of 80.8% salary and 19.2% bonuses, including company stock and options. directly owns 1.48% of the company’s shares, worth HK$3.73M. The average tenure of the management team and the board of directors is 2.1 years and 7.9 years respectively.
Key information
Raymond Choi
Chief executive officer
HK$1.5m
Total compensation
| CEO salary percentage | 80.8% |
| CEO tenure | 1.3yrs |
| CEO ownership | 1.5% |
| Management average tenure | 2.1yrs |
| Board average tenure | 7.9yrs |
Recent management updates
Recent updates
Returns On Capital Are Showing Encouraging Signs At Vincent Medical Holdings (HKG:1612)
Dec 21
Vincent Medical Holdings (HKG:1612) Is Experiencing Growth In Returns On Capital
Aug 29Is Vincent Medical Holdings (HKG:1612) Using Too Much Debt?
May 30Is Vincent Medical Holdings (HKG:1612) Using Too Much Debt?
Dec 15One Analyst Thinks Vincent Medical Holdings Limited's (HKG:1612) Revenues Are Under Threat
Aug 07Vincent Medical Holdings' (HKG:1612) Returns Have Hit A Wall
Aug 06Vincent Medical Holdings' (HKG:1612) Dividend Will Be Reduced To HK$0.025
May 25Vincent Medical Holdings' (HKG:1612) Dividend Will Be Reduced To HK$0.025
Apr 27Vincent Medical Holdings (HKG:1612) Will Pay A Smaller Dividend Than Last Year
Apr 07Under The Bonnet, Vincent Medical Holdings' (HKG:1612) Returns Look Impressive
Mar 08Downgrade: Here's How This Analyst Sees Vincent Medical Holdings Limited (HKG:1612) Performing In The Near Term
Jul 27Is Vincent Medical Holdings (HKG:1612) A Risky Investment?
Jun 06One Vincent Medical Holdings Limited (HKG:1612) Analyst Just Slashed Their Estimates By A Material 13%
Mar 28Vincent Medical Holdings Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Mar 25Vincent Medical Holdings (HKG:1612) Knows How To Allocate Capital
Mar 23Have Insiders Been Buying Vincent Medical Holdings Limited (HKG:1612) Shares This Year?
Mar 04I Ran A Stock Scan For Earnings Growth And Vincent Medical Holdings (HKG:1612) Passed With Ease
Feb 17Is There An Opportunity With Vincent Medical Holdings Limited's (HKG:1612) 42% Undervaluation?
Feb 04
What You Need To Know About Vincent Medical Holdings Limited's (HKG:1612) Investor Composition
Jan 22Investors Who Bought Vincent Medical Holdings (HKG:1612) Shares A Year Ago Are Now Up 267%
Jan 08Has Vincent Medical Holdings Limited's (HKG:1612) Impressive Stock Performance Got Anything to Do With Its Fundamentals?
Dec 26What We Learned About Vincent Medical Holdings' (HKG:1612) CEO Compensation
Dec 14Did Vincent Medical Holdings Limited (HKG:1612) Insiders Buy Up More Shares?
Dec 02Can Vincent Medical Holdings (HKG:1612) Keep Up These Impressive Returns?
Nov 20CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | HK$2m | HK$1m | HK$57m |
Compensation vs Market: Raymond's total compensation ($USD193.88K) is about average for companies of similar size in the Hong Kong market ($USD232.66K).
Compensation vs Earnings: Insufficient data to compare Raymond's compensation with company performance.
CEO
Raymond Choi (40 yo)
1.3yrs
Tenure
HK$1,515,000
Compensation
Mr. Cheung Tai Choi, also known as Raymond, served as Deputy Chief Executive Officer of Vincent Medical Holdings Limited since January 1, 2022 until January 1, 2023 and serves as its Chief Executive Office...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 8.5yrs | HK$1.49m | 1.68% HK$ 4.2m | |
| CEO & Executive Director | 1.3yrs | HK$1.52m | 1.48% HK$ 3.7m | |
| VP of OEM Business & Executive Director | no data | HK$1.47m | 0.78% HK$ 2.0m | |
| Executive Director | no data | HK$1.42m | 0.93% HK$ 2.3m | |
| Chief Financial Officer | no data | no data | no data | |
| Associate Director of Operations | no data | no data | no data | |
| Head of Investor Relations | no data | no data | no data | |
| Vice President of Sales & Marketing | no data | no data | no data | |
| Head of Sales & Marketing of Greater China | 2.1yrs | no data | no data | |
| Company Secretary | 7yrs | no data | no data |
2.1yrs
Average Tenure
50yo
Average Age
Experienced Management: 1612's management team is considered experienced (2.1 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 8.5yrs | HK$1.49m | 1.68% HK$ 4.2m | |
| CEO & Executive Director | 1.3yrs | HK$1.52m | 1.48% HK$ 3.7m | |
| VP of OEM Business & Executive Director | 8.2yrs | HK$1.47m | 0.78% HK$ 2.0m | |
| Executive Director | 8.2yrs | HK$1.42m | 0.93% HK$ 2.3m | |
| Independent Non-Executive Director | 7.9yrs | HK$240.00k | no data | |
| Independent Non-Executive Director | 7.9yrs | HK$276.00k | no data | |
| Independent Non-Executive Director | 7.3yrs | HK$264.00k | no data | |
| Non Executive Director | less than a year | HK$99.00k | no data |
7.9yrs
Average Tenure
64yo
Average Age
Experienced Board: 1612's board of directors are considered experienced (7.9 years average tenure).